Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab

Shalini Yalamanchi, Harry W Flynn

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A 39-year-old male with decreased visual acuity and extensive macular hemorrhage and edema secondary to a hemiretinal vein occlusion was treated with multiple intravitreal injections of bevacizumab 1.25 mg every four to six weeks for over one year. Treatment outcomes were assessed by visual acuity and Cirrus spectral domain optical coherence tomography. Treatment resulted in ongoing visual and anatomic improvement, with resolution at the last visit.

Original languageEnglish
Pages (from-to)1509-1513
Number of pages5
JournalClinical Ophthalmology
Volume5
Issue number1
StatePublished - Oct 14 2011

Fingerprint

Macular Edema
Visual Acuity
Veins
Hemorrhage
Intravitreal Injections
Optical Coherence Tomography
Bevacizumab
Therapeutics

Keywords

  • Bevacizumab
  • Macular edema
  • Retinal vein occlusion

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab. / Yalamanchi, Shalini; Flynn, Harry W.

In: Clinical Ophthalmology, Vol. 5, No. 1, 14.10.2011, p. 1509-1513.

Research output: Contribution to journalArticle

@article{6c054f9098364283892631095273bd51,
title = "Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab",
abstract = "A 39-year-old male with decreased visual acuity and extensive macular hemorrhage and edema secondary to a hemiretinal vein occlusion was treated with multiple intravitreal injections of bevacizumab 1.25 mg every four to six weeks for over one year. Treatment outcomes were assessed by visual acuity and Cirrus spectral domain optical coherence tomography. Treatment resulted in ongoing visual and anatomic improvement, with resolution at the last visit.",
keywords = "Bevacizumab, Macular edema, Retinal vein occlusion",
author = "Shalini Yalamanchi and Flynn, {Harry W}",
year = "2011",
month = "10",
day = "14",
language = "English",
volume = "5",
pages = "1509--1513",
journal = "Clinical Ophthalmology",
issn = "1177-5467",
publisher = "Dove Medical Press Ltd.",
number = "1",

}

TY - JOUR

T1 - Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab

AU - Yalamanchi, Shalini

AU - Flynn, Harry W

PY - 2011/10/14

Y1 - 2011/10/14

N2 - A 39-year-old male with decreased visual acuity and extensive macular hemorrhage and edema secondary to a hemiretinal vein occlusion was treated with multiple intravitreal injections of bevacizumab 1.25 mg every four to six weeks for over one year. Treatment outcomes were assessed by visual acuity and Cirrus spectral domain optical coherence tomography. Treatment resulted in ongoing visual and anatomic improvement, with resolution at the last visit.

AB - A 39-year-old male with decreased visual acuity and extensive macular hemorrhage and edema secondary to a hemiretinal vein occlusion was treated with multiple intravitreal injections of bevacizumab 1.25 mg every four to six weeks for over one year. Treatment outcomes were assessed by visual acuity and Cirrus spectral domain optical coherence tomography. Treatment resulted in ongoing visual and anatomic improvement, with resolution at the last visit.

KW - Bevacizumab

KW - Macular edema

KW - Retinal vein occlusion

UR - http://www.scopus.com/inward/record.url?scp=81055125632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81055125632&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:81055125632

VL - 5

SP - 1509

EP - 1513

JO - Clinical Ophthalmology

JF - Clinical Ophthalmology

SN - 1177-5467

IS - 1

ER -